Young women's breast cancer differ

Young women's breast cancer differ

The lack of clinical trials in breast cancer patients who are younger is claimed to be the cause of a problem their survival in the long term, United Kingdom research says.

The research funded by Cancer Research Institute in the United Kingdom and the Wessex Cancer Trust, found that certain types of cancer in patients who are young can quickly relapse after five years. This is a stark contrast with what usually happens on breast cancer.

This research analyzes that almost any number of 3,000 women aged under 40 years in this country was diagnosed with breast cancer. This amount is the 5% of the total number of breast cancer patients in the country.

The Data, published by the Journal of the National Cancer Institute showed that the number of patients surviving 5 years after diagnosis reached 85%. But in the eight years, this figure being 68%.

The real problem

Breast cancer generally found in women who have entered the age of menopause. This cancer can usually be treated with chemotherapy and continued with the granting of a remedy that tamoxifen for five years to block a receptor ekstrogen.

The researchers said that taking tamoxifen may help in the long run. Yet they still argue that this cancer testing need to involve more young women.

The Chairman of the research, Professor Dianna Eccles, said: "this study adds evidence that breast cancer can be very different when diagnosed in younger women. This type of cancer may need different treatment approaches. "

Kate Law, Director of clinical research of the Institute of cancer research United Kingdom, says: "in general the life chances of the women diagnosed with cancer is twice larger than those diagnosed in the 1970s. However, not the case with the patients from the younger age group."

Source: BBC Indonesia